#SpecialIssue CAR T-cell therapy has been demonstrated to be effective in CD19-positive blood cancers; thus, this offers great hope for a wide range of aggressive tumors that has so far demonstrated limited response to current treatments. The following special issue aimed to provide advances in T cells engineered with Fcγ-chimeric receptors (CRs) redirected against solid tumors and blood malignancies. 📚 Recent Prospectives in CAR T-based Therapy for Solid and Hematological Malignancies 📝 Guest Editors Dr. Carlo Cenciarelli Prof. Dr. Hany Marei Check out all 11 published papers 👇 https://lnkd.in/dkbDYgRP #medicine #health #research #science
Researcher presso CNR-IFT
1yProud to be the Guest Editor